Special report: "Trans Fat, Regulation, Legislation and Human Health"

Clinical Therapeutics features a special report in its March issue focusing on the science and policy leading up to the US Food and Drug Administration’s (FDA) preliminary steps toward restricting industrially produced trans fatty acids, or trans fat, at the federal level.

See the rest here:
Special report: "Trans Fat, Regulation, Legislation and Human Health"

Leave a Reply